The debate over high-priced specialty drugs came to an abrupt end on Tuesday in the California Legislature when a bill to make drug pricing more transparent was withdrawn from the Assembly Committee on Health by its author.
“I am going to be pulling this bill,” said Assembly member David Chiu (D-San Francisco) as he was called upon to introduce AB 463, which would have required drug companies to issue a report on the cost of any drug in excess of $10,000 a year. Read more.
English
Arabic
Chinese (Simplified)
Dutch
Filipino
French
German
Hindi
Hmong
Italian
Japanese
Khmer
Korean
Lao
Portuguese
Russian
Spanish
Vietnamese